Pharma PR Newswire

Pharma Focus Asia offers the most advanced strategies in Pharmaceutical Sector, the most significant developments in the industry and provides information on the latest research in Pharma Healthcare. The following Press Releases highlights the recent happenings in the Pharmaceutical Sector across the world.

Swedish Orphan Biovitrum AB: First Patients Enrolled in 24 Month Real-world Study Evaluating Effectiveness of Elocta®

Thursday, January 19, 2017
PR Newswire

STOCKHOLM Sweden Jan 19 2017 PRNewswire Swedish Orphan Biovitrum AB publ Sobi today announces that the first patients have been enrolled in the ASURE study NCT02976753 ASURE is a 24month realworld study evaluating the effectiveness of Elocta compared to conventional FVIII products in the prophyl..

PharmAthene and Altimmune Announce Merger to Create Immunotherapeutics Company Targeting Infectious Diseases

Thursday, January 19, 2017
PR Newswire

ANNAPOLIS Md and GAITHERSBURG Md Jan 19 2017 PRNewswire PharmAthene Inc NYSE MKT PIP and Altimmune Inc a privatelyheld immunotherapeutics company targeting infectious diseases announced today the signing of a definitive agreement for the merger of PharmAthene and Altimmune in an allstock transacti..

Oncolytics Biotech® Inc. Appoints Dr. Matt Coffey to the Role of President and CEO

Thursday, January 19, 2017
PR Newswire

CALGARY Jan 19 2017 PRNewswire Oncolytics Biotech Inc Oncolytics or the Company TSX ONC OTCQX ONCYF today announced that Matt Coffey PhD MBA has been appointed to the role of President and Chief Executive Officer effective immediately Dr Coffey had been serving as the Companys Interim President a..

U.S. FDA Approves IMBRUVICA® (ibrutinib) as First Treatment Specifically Indicated for Relapsed/Refractory Marginal Zone Lymphoma (MZL) - a Rare Type of Non-Hodgkin\'s Lymphoma

Thursday, January 19, 2017
PR Newswire

NORTH CHICAGO Ill Jan 19 2017 PRNewswire AbbVie NYSE ABBV a global biopharmaceutical company today announced the US Food and Drug Administration FDA approved IMBRUVICA ibrutinib for the treatment of patients with relapsedrefractory RR marginal zone lymphoma MZL who require systemic therapy and ha..

ArmaGen Appoints Mathias Schmidt, Ph.D., as Chief Executive Officer

Thursday, January 19, 2017
PR Newswire

CALABASAS Calif Jan 19 2017 PRNewswire ArmaGen Inc today announced that it has appointed Mathias Schmidt PhD as chief executive officer as well as a member of ArmaGens board of directors DrSchmidt brings to ArmaGen more than 17 years of executive management experience focused on the research and d..

AquaBounty Announces Completion of NASDAQ Listing and Equity Subscription from Intrexon

Thursday, January 19, 2017
PR Newswire

MAYNARD Mass Jan 19 2017 PRNewswire AquaBounty Technologies Inc AIM ABTU NASDAQ AQB a biotechnology company focused on enhancing productivity in aquaculture and a majorityowned subsidiary of Intrexon Corporation NYSE XON announces that it has completed the listing of its common shares on the NASD..

U.S. FDA Acknowledges Receipt of Shire\'s New Drug Application for SHP465 for ADHD

Thursday, January 19, 2017
PR Newswire

LEXINGTON Massachusetts January 19 2017 PRNewswire Shire plc LSE SHP NASDAQ SHPG announced that the US Food and Drug Administration FDA has acknowledged receipt of the Class 2 resubmission of a New Drug Application NDA for SHP465 a longacting triplebead mixed amphetamine salts formulation SHP465..

IMBRUVICA® (ibrutinib) Approved by FDA for Marginal Zone Lymphoma (MZL) Patients Who Require Systemic Therapy and Have Received At Least One Prior Anti-CD20-Based Therapy

Thursday, January 19, 2017
PR Newswire

HORSHAM Pa Jan 19 2017 PRNewswire The US Food and Drug Administration FDA has approved IMBRUVICA ibrutinib for the treatment of patients with marginal zone lymphoma MZL who require systemic therapy and have received at least one prior antiCD20based therapy1 Accelerated approval was granted for th..

Can-Fite BioPharma Announces $5 Million Registered Direct Offering

Thursday, January 19, 2017
PR Newswire

PETACH TIKVA Israel Jan 19 2017 PRNewswire CanFite BioPharma Ltd NYSE MKT CANF TASECFBI a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer and inflammatory diseases today announced that it has entered into definitive agreements with institutional i..

Allergan Announces FDA Approval Of RHOFADE™ (Oxymetazoline Hydrochloride) Cream, 1% For The Topical Treatment Of Persistent Facial Erythema Associated With Rosacea In Adults

Thursday, January 19, 2017
PR Newswire

DUBLIN Jan 19 2017 PRNewswire Allergan plc NYSE AGN a leading global pharmaceutical company announced today the approval of RHOFADE cream by the US Food and Drug Administration FDA for the topical treatment of persistent facial erythema redness associated with rosacea in adults Approval was based ..

Reproducibility Project: Cancer Biology Publishes First Five Replication Studies Conducted By Science Exchange

Thursday, January 19, 2017
PR Newswire

PALO ALTO Calif Jan 192017 PRNewswire Science Exchange the leading marketplace for scientific research is excited to announce that the first five replication studies from the Reproducibility Project Cancer BiologyRPCB have been published in eLife today Despite intense scrutiny around reproducibili..

Symbiomix Therapeutics Submits New Drug Application to US FDA for Solosec™ for the Treatment of BV

Thursday, January 19, 2017
PR Newswire

NEWARK NJ Jan 19 2017 PRNewswire Symbiomix a biopharmaceutical company bringing innovative medicines to market for prevalent gynecological infections today announced submission of a new drug application NDA for Solosec secnidazole oral granules for the treatment of bacterial vaginosis BV to the U..

Two More Leading Pharmaceutical Companies to Rely on psiXchange for Process Automation

Thursday, January 19, 2017
PR Newswire

KAISERSLAUTERN Germany January 19 2017 PRNewswire pharmasol a global leader in software development and product implementation for the life sciences industry today announced two new pharmaceutical customers for its flagship product psiXchange psiXchange supports the automation control and manag..

Milner Therapeutics Institute Announces New Partnership with US Pharmaceutical Company Pfizer

Thursday, January 19, 2017
PR Newswire

CAMBRIDGE England January 19 2017 PRNewswire Pfizer joins Astex AstraZeneca GlaxoSmithKline Shionogi MedImmune and Otsuka in the Milner Therapeutics Consortium Major research investment to work with academic scientists in Cambridge The Milner Therapeutics Institute today announces Pfizer Inc N..

Hopeful of Reduced Regulation, Biotech Stocks Stay the Course with Advanced Drug Developments

Thursday, January 19, 2017
PR Newswire

PALM BEACH Florida January 19 2017 PRNewswire While various reports indicate the incoming Trump administration appears serious about reducing the FDAs regulatory strictness as a way to boost advancements and innovation in the medical drug industry many of the leading biotech and pharmaceutical c..

German Research Foundation (DFG) Purchases ViewRay MRIdian Linac for University Clinic Heidelberg

Thursday, January 19, 2017
PR Newswire

CLEVELAND Jan 19 2017 PRNewswire ViewRay Inc Nasdaq VRAYannounced today that the German Research Foundation DFG a federal institution supporting research in Germany has purchased a MRIdian Linac for installation and patient treatments at the University Clinic Heidelberg as part of its initiative ..

Medicationdiscountcard.com Launches New Online Feature for Comparison Shopping of Prescription Drugs

Thursday, January 19, 2017
PR Newswire

ATLANTIC CITY NJ Jan 19 2017 PRNewswire Many patients dont realize that they may be paying over 100 for their medication when a pharmacy just a few blocks away charges only 25 for the same exact prescription To alleviate this problem Medicationdiscountcardcom has created a price comparison engine..

Medical Marijuana, Inc. Investment AXIM® Biotech Enters IBS Clinical Trial With CBD Chewing Gum

Thursday, January 19, 2017
PR Newswire

SAN DIEGO Jan 19 2017 PRNewswire Medical Marijuana Inc OTC MJNA the firstever publicly traded cannabis company in the United States announced today that its major investment company AXIM Biotechnologies Inc AXIM Biotech OTC AXIM has entered clinical trials at Wageningen University in the Netherlan..

Stealth BioTherapeutics Announces New Appointments to Senior Leadership Team

Thursday, January 19, 2017
PR Newswire

BOSTON Jan 19 2017 PRNewswire Stealth BioTherapeutics Inc Stealth a clinicalstage biopharmaceutical company developing therapeutics to treat mitochondrial dysfunction today announced new additions to its senior leadership team W Douglas Weaver MD as Chief Medical Officer and Daniel Geffken as inte..

Biocept Awarded Patent in Australia for the Use of Antibodies in Microchannels to Capture Circulating Tumor Cells and Other Rare Cells

Thursday, January 19, 2017
PR Newswire

SAN DIEGO Jan 19 2017 PRNewswire Biocept Inc NASDAQ BIOC a leading commercial provider of clinically actionable liquid biopsy tests to improve the management of cancer patients announces that it has been awarded Australian Patent No 2010229924 entitled DEVICES AND METHODS OF CELL CAPTURE AND ANALY..

TOP